Back to today’s briefing

Story perspectives

Vinay Prasad's FDA Exit Sparks Controversy Over Gene Therapies

8/1/2025

32 5

Summary

Story summary

Vinay Prasad's departure from the FDA has stirred controversy, particularly regarding his choices on gene therapies and Covid vaccines. While some stakeholders may welcome the change, it raises concerns about the agency's commitment to scientific integrity. Prasad defended his decisions as efforts to safeguard public interest and ensure accurate risk evaluations.

1 of 1

Story summary

Vinay Prasad's departure from the FDA has stirred controversy, particularly regarding his choices on gene therapies and Covid vaccines. While some stakeholders may welcome the change, it raises concerns about the agency's commitment to scientific integrity. Prasad defended his decisions as efforts to safeguard public interest and ensure accurate risk evaluations.